FDA Adverse Event
Injury
Summary report: N
SOMRYST
MDR report key: 17922952
·
Received October 11, 2023
Report
- Report Number
- MW5146841
- Event Type
- Injury
- Date Received
- October 11, 2023
- Date of Event
- May 22, 2022
- Report Date
- October 5, 2023
- Manufacturer
- PEAR THERAPEUTICS, INC.
- Product Code
- QVO
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Occupation
- PATIENT
- Health Professional
- *
Narratives
Description of Event or Problem · 0
I HAVE DEVELOPED TETANUS, SEVERE NECK PAIN, SEIZURES, ANXIETY, AND INSOMNIA FROM THE COVID VACCINE. THE COVID TESTS BY ROCHE WERE EVIDENTLY COVERED IN A BIOLFILM THAT INTRODUCED BACTERIA INTO THE NASAL CAVITY. SOMRYST IS COUNTER INDICATED FOR SEIZURES WHICH THE PROVIDER KNEW. SEIZURE DISORDER, CANNOT USE SOMRYST, SERVICE DOG FOR SEIZURES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1768008 | SOMRYST | COMPUTERIZED BEHAVIORAL THERAPY DEVICE FOR INSOMNIA | QVO | PEAR THERAPEUTICS, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 35 YR | Female | Disability |